Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458507084264v1
14/3/314    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Google Scholar
Right arrow Articles by Tremlett, H.
Right arrow Articles by Devonshire, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tremlett, H.
Right arrow Articles by Devonshire, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on April 1, 2008
Multiple Sclerosis, Vol. 14, No. 3, 314-324 (2008)
DOI: 10.1177/1352458507084264
© 2008 SAGE Publications

Natural history of secondary-progressive multiple sclerosis

Helen Tremlett

Department of Medicine (Neurology), rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver BC V6T 2B5, Canada, tremlett{at}interchange.ubc.ca, Department of Health Care and Epidemiology, rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver BC V6T 2B5, Canada

Yinshan Zhao

MS/MRI Research Group, rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver BC V6T 2B5, Canada

Virginia Devonshire

Department of Medicine (Neurology), rm S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver BC V6T 2B5, Canada

Objective To examine prognosis and risk factors for progression to and from secondary-progressive multiple sclerosis (SPMS).

Methods Patients with definite relapsing—remitting MS (RRMS), onset before July 1988, attending a British—Columbian MS clinic before July 1998, and at least one Expanded Disability Status Scale (EDSS) scores were selected from the population-based database. Time to SPMS (from onset and birth) and the subsequent time to EDSS 8 were examined, as were potential risk factors.

Results In all, 2484/2837 (87.6%) were relapsing—remitting (RR) at onset, with 1445/2484 (58.2%) reaching SPMS, taking a median 18.9 years (95% CI: 18.2—19.7). Those younger at onset took longer to reach SPMS (P < 0.0005), but did so at a younger age (P < 0.0005). Males reached SPMS more rapidly from onset and at a younger age (P < 0.0005), but were around the same age as females at EDSS 8 (P = 0.975). Characteristics at SPMS onset associated with a longer time from SPMS to EDSS 8 and an older age at EDSS 8 were: longer disease duration (P < 0.02), older age (P < 0.01) and lower EDSS (P < 0.0005). Onset symptoms had little influence on time to SPMS or subsequent progression.

Conclusions The RR phase lasted on average almost two decades, being shorter for males and those older at onset of MS. However, neither were necessarily unfavorable predictors as those older at onset were typically older at SPMS and eventually males and females reached EDSS 8 at around the same age. A longer RR phase was a favorable predictor of disease progression in SPMS. Furthermore, reaching SPMS at an older age or lower EDSS did not necessarily confer a worse outcome. Multiple Sclerosis 2008; 14: 314—324. http://msj.sagepub.com

Key Words: disease progression • multiple sclerosis • natural history • secondary-progressive • survival analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
C. Confavreux
Defining the natural history of MS: the need for complete data and rigorous definitions
Multiple Sclerosis, April 1, 2008; 14(3): 289 - 291.
[PDF]